TFX - Teleflex Incorporated
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $3.73
|
Rev Est: $912.6M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$131.00
DETAILS
HIGH:
$138.00
LOW:
$116.00
MEDIAN:
$135.00
CONSENSUS:
$131.00
UPSIDE:
16.84%
Market Cap:
4.96B
Volume:
591,384
Avg Volume:
890,548
52 Week Range:
100.18-180.58
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.91
Last Dividend:
$1.36
Exchange:
NYSE
Country:
US
Employees:
14,100
IPO Date:
1980-03-17
EPS (TTM):
1.49
P/E Ratio:
119.64
Revenue (TTM):
3.05B
Total Assets:
7.10B
Total Debt:
1.76B
Cash & Equiv:
290.19M
Rev Growth (5Y):
3.3%
EPS Growth (5Y):
-31.6%
FCF Growth (5Y):
8.6%
ROCE:
2.5%
Debt/Equity:
0.41
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $3.67 | $3.38 | +8.6% | $913.0M | $915.0M | -0.2% |
| 2025-07-31 | $3.73 | $3.36 | +11.0% | $780.9M | $892.9M | -12.5% |
| 2025-05-01 | $2.91 | $2.88 | +1.0% | $700.7M | $766.1M | -8.5% |
| 2025-02-27 | $3.89 | $3.86 | +0.8% | $795.4M | $767.1M | +3.7% |
| 2024-10-31 | $3.49 | $3.38 | +3.3% | $764.4M | $813.3M | -6.0% |
| 2024-08-01 | $3.42 | $3.33 | +2.7% | $749.7M | $763.0M | -1.7% |
| 2024-05-02 | $3.21 | $3.07 | +4.6% | $737.8M | $726.9M | +1.5% |
| 2024-02-22 | $3.38 | $3.26 | +3.7% | $773.9M | $768.7M | +0.7% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.05B | 2.97B | 2.79B | 2.81B | 2.54B | 2.60B | 2.45B | 2.15B | 1.87B | 1.81B | 1.84B | 1.70B |
| Net Income | 69.67M | 356.33M | 363.14M | 485.37M | 335.32M | 461.47M | 200.80M | 152.53M | 237.38M | 244.86M | 187.68M | 150.88M |
| EPS | 1.49 | 7.58 | 7.74 | 10.38 | 7.21 | 9.99 | 4.39 | 3.39 | 5.48 | 5.89 | 4.54 | 3.67 |
| Total Assets | 7.10B | 7.53B | 6.93B | 6.87B | 7.15B | 6.31B | 6.28B | 6.18B | 3.89B | 3.88B | 3.98B | 4.21B |
| Total Debt | 1.76B | 1.93B | 1.83B | 1.97B | 2.56B | 2.01B | 2.16B | 2.25B | 1.03B | 1.07B | 1.07B | 1.29B |
| Cash & Equivalents | 290.19M | 222.85M | 292.03M | 445.08M | 375.88M | 301.08M | 357.16M | 333.56M | 543.79M | 338.37M | 303.24M | 431.98M |
| Operating Cash Flow | 635.74M | 510.64M | 342.14M | 651.42M | 436.41M | 439.52M | 437.38M | 419.88M | 408.48M | 300.81M | 286.56M | 226.54M |
| Free Cash Flow | 509.31M | 419.20M | 262.95M | 579.80M | 345.71M | 336.83M | 356.58M | 348.98M | 355.35M | 239.36M | 218.99M | 162.96M |
| FCF per Share | 10.87 | 8.92 | 5.61 | 12.40 | 7.44 | 7.29 | 7.80 | 7.75 | 8.20 | 5.76 | 5.29 | 3.96 |
| Book Value | 4.28B | 4.44B | 4.02B | 3.75B | 3.34B | 2.98B | 2.54B | 2.43B | 2.14B | 2.01B | 1.91B | 1.91B |
| Cash & ST Investments | 306.16M | 222.85M | 292.03M | 445.08M | 375.88M | 301.08M | 357.16M | 333.56M | 543.79M | 338.37M | 303.24M | 431.98M |
| ROC Equity | 0.02 | 0.08 | 0.09 | 0.13 | 0.10 | 0.15 | 0.08 | 0.06 | 0.11 | 0.12 | 0.10 | 0.08 |